THE Therapeutic Goods Administration (TGA) has recently handed out fines to both Nius Development and EmpireLabz Australia.
Nius Development were issued two infringement notices totalling $26,640 for the alleged unlawful import of unapproved cosmetic injectable products.
The TGA alleged that the company attempted to import medical devices containing prescription-only substances, without approval or authority.
It also issued seven infringement notices totalling $115,500 to EmpireLabz Australia for the alleged unlawful advertising and supply of sport supplement products not included in the Australian Register of Therapeutic Goods (ARTG).
The products were found to contain banned substances and prescription-only ingredients.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Aug 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Aug 23
